Emerging ultrafast nucleic acid amplification technologies for next-generation molecular diagnostics.

Area of Science:

• Molecular Biology
• Biotechnology
• Medical Diagnostics

Background:

• Nucleic acid amplification tests (NAATs), including polymerase chain reaction (PCR), are gold standards for diagnosing diseases due to high sensitivity and specificity.
• Traditional NAATs face limitations such as long run times, large volumes, and complex protocols, hindering point-of-care applications.

Purpose of the Study:

• To review recent advances in ultrafast nucleic acid amplification tests for point-of-care testing (NA-POCT).
• To provide an overview of NA-POCT platforms, focusing on sample preparation, amplification, detection, and design.
• To highlight innovative methods incorporating AI and mobile healthcare for NA-POCT.

Main Methods:

• Review of existing literature on ultrafast NAATs and POCT platforms.
• Analysis of NA amplification principles and detection processes in current NA-POCT systems.
• Evaluation of platform designs, sample preparation, and data interpretation in NA-POCT.

Main Results:

• Emerging ultrafast NA-POCT platforms address the limitations of traditional NAATs, enabling rapid sample-to-answer diagnostics.
• Innovative amplification methods and AI-driven data analysis are enhancing NA-POCT capabilities.
• Integration with mobile-healthcare networks is expanding the reach and utility of NA-POCT.

Conclusions:

• Ultrafast NA-POCT platforms are crucial for meeting clinical and research demands for rapid diagnostics.
• These platforms hold significant promise for precision medicine through absolute nucleic acid quantitation at the individual level.
• Future developments will likely focus on AI integration and mobile health networks for advanced NA-POCT.